Nice to see you here!

Forbidden Universe

*
BELIEVE
Welcome, Guest. Please login or register.

Login with username, password and session length

News:

Welcome to Forbidden Universe let us take you to the outer limits! Feel free to check out the following links upon joining us.

www.paranormalghostsociety.org
https://plus.google.com/communities/110322788271008715603
https://www.facebook.com/TheParanormalAndGhostSociety
https://www.facebook.com/groups/ParanormalGhostSociety
https://www.facebook.com/AngelOfThyNight
www.twitter.com/AngelOfThyNight
www.youtube.com/AngelOfThyNight


  • Home
  • Help
  • Search
  • Arcade
  • Calendar
  • Contact
  • Members
    • View the memberlist
    • Search For Members
  • Login
  • Register

  • Forbidden Universe >>
  • General Category >>
  • Domestic & World News >>
  • FDA approves ketamine-like nasal spray for depression
« previous next »
  • Print
Pages: [1]   Go Down

Author Topic: FDA approves ketamine-like nasal spray for depression  (Read 437 times)

0 Members and 1 Guest are viewing this topic.

AngelOfThyNight

  • Guest
FDA approves ketamine-like nasal spray for depression
« on: March 06, 2019, 06:24:23 PM »
FDA approves ketamine-like nasal spray for depression

The US Food and Drug Administration approved Janssen Pharmaceuticals Inc.'s esketamine on Tuesday for treatment-resistant depression; the drug is the chemical cousin of ketamine, the powerful anesthetic that has been used illegally as the club drug Special K.



Source: FDA approves ketamine-like nasal spray for depression
Tweet Logged

  • Print
Pages: [1]   Go Up
« previous next »
  • Forbidden Universe >>
  • General Category >>
  • Domestic & World News >>
  • FDA approves ketamine-like nasal spray for depression
 

INFO


  • Welcome
  • People
  • Management

LOCATION


  • Map
  • Address
  • Contact Us

ABOUT


  • Company
  • Terms

CREDITS


  • SMF | SMF © 2015, Simple Machines
    Simple Audio Video Embedder
  • XHTML
  • RSS
  • WAP2


Copyright 2011-2014. All Rights Reserved.

Designed by Surface Themes.